Prof Walter Jaoko Publications
PDF version
  1. A 15year study of the impact of community antiretroviral therapy coverage on  HIV incidence in Kenyan female sex workers
  2. A Prospective Cohort Study of Intimate Partner Violence and Unprotected Sex in
    HIV‐Positive Female Sex Workers in Mombasa, Kenya
    .
  3. A Prospective Study of Intimate Partner Violence as a Risk Factor for Detectable
    Plasma Viral Load in HIV‐Positive Women Engaged in Transactional Sex in Mombasa, Kenya.
  4. Baboon vaginal microbial flora.
  5. Changes in Vaginal Microbiota and Immune Mediators in HIV‐1‐Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate.
  6. Correlates of the molecular vaginal microbiota composition of African women
  7. MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS‐ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.
  8. Prevalence and correlates of intimate partner violence in HIV‐positive women engaged in transactional sex in Mombasa, Kenya.
  9. Reducing IRF‐1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.
  10. The Relationship Between Distance and Post‐operative Visit Attendance Following Medical Male Circumcision in Nyanza Province, Kenya.
  11. Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.
  12. A prospective cohort study of the effect of depot medroxyprogesterone acetate ondetection of plasma and cervical HIV‐1 in women initiating and continuing antiretroviral therapy.
  13. Age and menopause affect the expression of specific cytokines/chemokines in plasma and cervical lavage samples from female sex workers in Nairobi, Kenya
  14. An effective intervention to reduce intravaginal practices among HIV‐1
    uninfected Kenyan women.
  15. Association between alcohol use and sexually transmitted infection incidence among kenyan women engaged in transactional sex.
  16. Association between cellular immune activation, target cell frequency, and risk of human immunodeficiency virus type 1 superinfection.
  17. Changes in sexual risk behavior in the Mombasa cohort: 1993‐2007.
  18. Elevation of soluble intercellular adhesion molecule‐1 levels, but not
    angiopoietin 2, in the plasma of human immunodeficiency virus‐infected African women with clinical Kaposi sarcoma.
  19. HIV‐1 superinfection is associated with an accelerated viral load increase but has a limited impact on disease progression.
  20. HIV‐1 superinfection occurs less frequently than initial infection in a cohort
    of high‐risk Kenyan women.
  21. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.
  22. Long‐term follow‐up of study participants from prophylactic HIV vaccine clinical trials in Africa.
  23. Oral HHV‐8 replication among women in Mombasa, Kenya.
  24. PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine
    administered to infants born to human immunodeficiency virus type 1‐positive mothers in Nairobi.
  25. Prevalence and correlates of bacterial vaginosis in different sub‐populations of women in sub‐Saharan Africa: a cross‐sectional study.
  26. Risk compensation following male circumcision: results from a two‐year
    prospective cohort study of recently circumcised and uncircumcised men in NyanzaProvince, Kenya.
  27. Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV‐infected women.
  28. Systemic cytokine levels show limited correlation with risk of HIV‐1
    acquisition.
  29. Urinary cytokines in Schistosoma haematobium‐infected schoolchildren from Tana Delta District of Kenya.
  30. Vaccines against sexually transmitted infections: the way forward.
  31. A prospective study of endothelial activation biomarkers, including plasma
    angiopoietin‐1 and angiopoietin‐2, in Kenyan women initiating antiretroviral therapy
    .
  32. Antibody‐dependent cell‐mediated virus inhibition antibody activity does not correlate with risk of HIV‐1 superinfection.
  33. Association between alcohol use and sexually transmitted infection incidence among kenyan women engaged in transactional sex.
  34. Changes in plasma viral load and penile viral shedding after circumcision among HIV‐positive men in Kisumu, Kenya.
  35. Endothelial activation biomarkers increase after HIV‐1 acquisition: plasma
    vascular cell adhesion molecule‐1 predicts disease progression.
  36. Factors associated with resumption of sex before complete wound healing in circumcised HIV‐positive and HIV‐negative men in Kisumu, Kenya.
  37. HIV‐1 superinfection occurs less frequently than initial infection in a cohort
    of high‐risk Kenyan women.
  38. Incidence and correlates of Chlamydia trachomatis infection in a high‐risk
    cohort of Kenyan women.
  39. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis.
  40. Interferon regulatory factor 1 polymorphisms previously associated with reduced HIV susceptibility have no effect on HIV disease progression.
  41. Long‐term follow‐up of study participants from prophylactic HIV vaccine clinical trials in Africa.
  42. Loss to follow‐up as a competing risk in an observational study of HIV‐1
    incidence.
  43. Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV‐infected women.
  44. Systemic cytokine levels show limited correlation with risk of HIV‐1
    acquisition.
  45. Time to complete wound healing in HIV‐positive and HIV‐negative men following
    medical male circumcision in Kisumu, Kenya: a prospective cohort study.
AttachmentSize
MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.pdf43.33 KB